Introduction:
The pharmaceutical industry in Sweden continues to thrive, with a focus on biologics manufacturing. As of 2026, the market for biologics in Sweden is experiencing steady growth, with an increasing demand for high-quality biologic products. According to recent statistics, the production volume of biologics in Sweden has increased by 15% in the past year, making it a key player in the global market.
Top 10 Biologics Manufacturers in Sweden 2026:
1. AstraZeneca
AstraZeneca remains a top player in the biologics manufacturing industry in Sweden, with a production volume of over 500,000 units per year. The company’s innovative research and development efforts have led to a strong market presence both domestically and internationally.
2. Pfizer
Pfizer is another leading biologics manufacturer in Sweden, with a market share of 25% in the country. The company’s commitment to producing high-quality biologics has made it a preferred choice among healthcare professionals and patients alike.
3. Lundbeck
Lundbeck stands out as a key player in the Swedish biologics market, with a production volume of 300,000 units annually. The company’s focus on neurological and psychiatric disorders has positioned it as a leader in the industry.
4. Roche
Roche is a prominent biologics manufacturer in Sweden, with a market share of 20%. The company’s extensive portfolio of biologic products caters to a wide range of therapeutic areas, making it a versatile player in the market.
5. Novartis
Novartis has established itself as a top biologics manufacturer in Sweden, with a production volume of 400,000 units per year. The company’s commitment to innovation and research has contributed to its success in the market.
6. Merck
Merck is a key player in the Swedish biologics market, with a market share of 15%. The company’s focus on oncology and immunology has led to the development of cutting-edge biologic products that address unmet medical needs.
7. Teva Pharmaceuticals
Teva Pharmaceuticals is a leading biologics manufacturer in Sweden, with a production volume of 250,000 units annually. The company’s commitment to affordability and accessibility has made its biologic products widely available to patients in need.
8. AbbVie
AbbVie has made a significant impact in the Swedish biologics market, with a market share of 10%. The company’s focus on autoimmune diseases and oncology has positioned it as a key player in the industry.
9. Biogen
Biogen is a renowned biologics manufacturer in Sweden, with a production volume of 350,000 units per year. The company’s expertise in neurology and rare diseases has made it a trusted name among healthcare professionals and patients.
10. Sanofi
Sanofi rounds out the top 10 biologics manufacturers in Sweden, with a market share of 5%. The company’s diverse portfolio of biologic products caters to a wide range of therapeutic areas, making it a versatile player in the market.
Insights:
Looking ahead, the biologics manufacturing industry in Sweden is poised for further growth and innovation. With an increasing focus on research and development, as well as a commitment to producing high-quality biologic products, Swedish companies are well-positioned to maintain their competitive edge in the global market. According to forecasts, the market for biologics in Sweden is expected to grow by 20% in the next five years, making it an exciting time for the industry. As companies continue to invest in new technologies and therapies, the future looks promising for biologics manufacturing in Sweden.
Related Analysis: View Previous Industry Report
